![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Anglo Asian Mining Plc | LSE:AAZ | London | Ordinary Share | GB00B0C18177 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
2.90 | 3.35% | 89.50 | 87.00 | 92.00 | 92.00 | 83.50 | 83.50 | 164,919 | 15:50:48 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Miscellaneous Metal Ores,nec | 45.86M | -24.24M | -0.2122 | -4.34 | 98.93M |
Date | Subject | Author | Discuss |
---|---|---|---|
17/4/2020 08:15 | MPH - taken a small starter position, that chart is just too irresistible Bumpa,,, we shall see,,, many thanx for heads up on it, GLA Cheers Wan :-) | wanobi | |
17/4/2020 08:12 | Go to 9 mins and listen to the jobless numbers and how they put it into perspective in population terms ?....https://youtu.b | ![]() onedayrodders | |
17/4/2020 07:32 | Also, Moderna Announces Award from U.S. Government Agency BARDA for up to $483 Million to Accelerate Development of mRNA Vaccine (m... 16/04/2020 10:55pm Business Wire | wanobi | |
17/4/2020 07:29 | that sounds very encouraging indeed Bumpa,,, fingers & toes crossed they have found a treatment that works... Cheers Wan :-) | wanobi | |
17/4/2020 07:28 | AVCT - RNS today Avacta Group PLC 17 April 2020 17 April 2020 Avacta Group plc ("Avacta" or "the Group" or "the Company") Notice of Results - Update Avacta Group plc (AIM: AVCT), the developer of Affimer(R) biotherapeutics and reagents, today announces that, due to the timing of the General Meeting and completion of the proposed Admission of both the Placing Shares and Subscription Shares on 23 April 2020, it will now announce its financial results for the 17 months ended 31 December 2019 on Wednesday, 6 May 2020. The analyst briefing due to be held on Tuesday, 21 April 2020 will now be held by Alastair Smith, Chief Executive Officer, and Tony Gardiner, Chief Financial Officer, by webcast presentation, followed by a Q&A session at 09.30 hrs on Wednesday, 6 May 2020. Pre-registration is required for attendance to the call. To confirm attendance, please email avacta@yellowjerseyp The shareholder and investor meeting that was due to be held on Wednesday, 22 April 2020 will now take place as a webcast presentation, followed by a Q&A session, at 17.00 hrs on Wednesday, 6 May 2020. You can register and access the shareholder and investor webcast via the following link: . Alastair Smith, Chief Executive Officer, and Tony Gardiner, Chief Financial Officer, will host the call and look forward to responding to questions from existing and prospective investors. | wanobi | |
17/4/2020 07:28 | Good morning, good luck and good health to you all today, cheers Wan :-) | wanobi | |
17/4/2020 06:58 | I have to say this is the best run, honest AIM company i have been in over the last 16 years, so ever. Every other one i have been in the managements have all lied. I have only been in here for the past 18 months but had been watching from the sidelines for a while. I wanted to get in but just kept looking at the chart thinking, i don't want to be sat on top of that spike. But the more this management did, the more i started to believe they were nothing like the other charlatans, that there are many out there. What you need is a very good board of directors, management and the workers on the ground. We have that here. | ![]() gold finger 1 | |
17/4/2020 06:12 | Well it seems that the real ries in gold will start towards the end of this year,beginning of next. Well that will suit AAZ, it will give them time to get one of those new targets up and running. We know it will take a year to get to production. Then they will be able to ramp up production into a rising gold price. Not that todays gold price is not very good. Lots of news to arrive here over the coming months and years. For the last year we have been doing a lot of exploration and building a large cash pile. I think from here we will start to see how the management intend to spend that cash pile to get us to a mid cap miner. In the meantime, we will just have to comfort ourselves with a boring company,that is making record profits and paying a healthy divi. If you are looking for a steady growth company, with a healthy divi, this is a place to be. If you are looking for a gamble,this is not the place to be. | ![]() gold finger 1 | |
17/4/2020 05:43 | Well if people didn't think the high street was dying before this virus they will see it very soon. We have seen in this lockdown that people can work from home. SO how many companies will think, why are we paying for these expensive offices when we don't need them. This will be the final nail in the coffin for the high street. They will soon be turned into apartments or just demolished and turned into housing. Well we need housing a lot more than we need a high street. Aimo. | ![]() gold finger 1 | |
17/4/2020 00:40 | Be interesting to see what the Gilead (sort of) news does to cv-19 plays tomorrow. | ![]() bumpa33 | |
17/4/2020 00:14 | Very, very well timed too - along with $BA news and Trumps speech to the nation. Es_F put on 90 points on (all) that - and triggered stops on the rest of my short 🙄 | ![]() bumpa33 | |
16/4/2020 23:58 | Very, very interesting Bumpa. | ![]() swallowsflysouth | |
16/4/2020 22:44 | aha, well done Bumpa, very interesting - ""Companies that want to buy their way into the TIGIT field have a few options, including Arcus. Other companies with anti-TIGIT drugs in their pipelines include iTeos Therapeutics and Mereo BioPharma."" Cheers Wan :-) | wanobi | |
16/4/2020 22:18 | And here’s the reason for the interest in Mereo... | ![]() bumpa33 | |
16/4/2020 22:13 | SP500 breaking above the 2850 resistance level! | ![]() brasso3 | |
16/4/2020 22:08 | This. Gilead shares surge after-hours as Stat News reports that the company's Remdesivir trial for coronavirus patients is seeing rapid recoveries according to early data | ![]() bumpa33 | |
16/4/2020 21:38 | AVCT - !? Cheers Wan :-) | wanobi | |
16/4/2020 20:51 | jbe - very true yes. Generally I hate ‘collecting | ![]() bumpa33 | |
16/4/2020 20:41 | Correct jbe, that’s how it often transpires many a pharma and oil play for that matter. | ![]() riggerbeautz | |
16/4/2020 20:00 | Taking AVCT as an example, if it is not successful there are a lot of people that won't be able to cash out paper profits, those that buy anywhere near the top will get seriously burnt, but people will make money on the way up. | ![]() jbe81 | |
16/4/2020 19:56 | Bumpa, if you trade the momentum you dont need the winner, as you know. | ![]() jbe81 | |
16/4/2020 19:30 | well done droyden, fingers crossed :-) Cheers Wan :-) | wanobi |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions